Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Interferon-alpha × Clear all

NCT00004122 2013-02-01

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms